WSAZ-TV |
Mylan CEO: 'Misconception' about EpiPen profits
USA TODAY The CEO of the drug maker that sells the EpiPen treatment is expected to defend the company's controversial price increases when she testifies before Congress on Wednesday amid a firestorm over pharmaceutical profits. Mylan CEO Heather Bresch said ... USA Today reports Gayle Manchin used position to boost EpiPen sales Mylan CEO's mother used position with education group to boost EpiPen sales nationwide Reviewing the Rising Price of EpiPens - United States House Committee on Oversight and Government Reform |
